在实体关系图表上的非线性数据融合用于药物目标相互作用预测
Eugenio Mazzone1, Yves Moreau2, Piero Fariselli1
1Department of Medical Sciences, University of Torino, 10123 Torino, Italy.
Bioinformatics (Oxford, England)
|May 31, 2023
概括
这项研究引入了一种新的数据融合方法,用于预测药物向相互作用 (DTI),优于现有的方法. 该方法在预测二元分类和实值亲和关系方面提供了灵活性,增强了药物设计和重定向努力.
科学领域:
- 计算化学是一种计算化学.
- 生物信息学是一种生物信息学.
- 机器学习是机器学习.
背景情况:
- 预测药物向相互作用 (DTI) 对于药物设计和重新定位至关重要.
- 现有的方法往往缺乏灵活性或需要更严格的验证.
研究的目的:
- 通过使用NXTfusion库,介绍一种用于DTI预测的新型数据融合方法.
- 在实体关系图表上对非线性推理进行矩阵因数分解的概括.
主要方法:
- 开发了用于DTI预测的数据融合方法.
- 扩展矩阵因子化对使用NXTfusion的实体关系图表进行非线性推理.
- 在五个数据集上与最先进的方法进行基准测试.
主要成果:
- 提出的模型在DTI预测任务上表现优于现有的方法.
- 该方法在预测二元DTI和实值药物标亲和力方面表现出灵活性.
- 结果表明,在现实环境中对DTI方法进行更严格的验证.
结论:
- 实体关系数据融合方法有效地整合了用于DTI预测的异质信息.
- 该方法为计算机辅助药物设计提供了灵活和高性能的解决方案.
- 对于DTI预测方法,建议采用模拟现实场景的更严格的验证.
相关概念视频
Quantitative Aspects of Drug-Receptor Interaction
1.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.1K
Drug-Receptor Interactions
5.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.4K
Drug-Receptor Bonds
3.0K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
3.0K
Agonism and Antagonism: Quantification
421
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
421
Drug-Receptor Interaction: Agonist
2.6K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.6K
Combined Effects of Drugs: Synergism
4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.1K


